130 related articles for article (PubMed ID: 21737255)
1. Over-expression of SERPINB3 in hepatoblastoma: a possible insight into the genesis of this tumour?
Turato C; Buendia MA; Fabre M; Redon MJ; Branchereau S; Quarta S; Ruvoletto M; Perilongo G; Grotzer MA; Gatta A; Pontisso P
Eur J Cancer; 2012 May; 48(8):1219-26. PubMed ID: 21737255
[TBL] [Abstract][Full Text] [Related]
2. SERPINB3 induces epithelial-mesenchymal transition.
Quarta S; Vidalino L; Turato C; Ruvoletto M; Calabrese F; Valente M; Cannito S; Fassina G; Parola M; Gatta A; Pontisso P
J Pathol; 2010 Jul; 221(3):343-56. PubMed ID: 20527027
[TBL] [Abstract][Full Text] [Related]
3. The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma.
Correnti M; Cappon A; Pastore M; Piombanti B; Lori G; Oliveira DVPN; Munoz-Garrido P; Lewinska M; Andersen JB; Coulouarn C; Sulpice L; Peraldo Neia C; Cavalloni G; Quarta S; Biasiolo A; Fassan M; Ramazzotti M; Parri M; Recalcati S; di Tommaso L; Campani C; Invernizzi P; Torzilli G; Marra F; Pontisso P; Raggi C
Liver Int; 2022 Jan; 42(1):233-248. PubMed ID: 34478594
[TBL] [Abstract][Full Text] [Related]
4. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of CD44 expression in children with hepatoblastoma.
Cai HY; Yu B; Feng ZC; Qi X; Wei XJ
Genet Mol Res; 2015 Oct; 14(4):13203-7. PubMed ID: 26535633
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
7. Maspin - the most commonly-expressed gene of the 18q21.3 serpin cluster in lung cancer - is strongly expressed in preneoplastic bronchial lesions.
Smith SL; Watson SG; Ratschiller D; Gugger M; Betticher DC; Heighway J
Oncogene; 2003 Nov; 22(54):8677-87. PubMed ID: 14647462
[TBL] [Abstract][Full Text] [Related]
8. Sarcomatoid hepatocellular carcinoma with hepatoblastoma-like features in an adult.
Cho MS; Lee SN; Sung SH; Han WS
Pathol Int; 2004 Jun; 54(6):446-50. PubMed ID: 15144405
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of squamous cell carcinoma antigen in idiopathic pulmonary fibrosis: clinicopathological correlations.
Calabrese F; Lunardi F; Giacometti C; Marulli G; Gnoato M; Pontisso P; Saetta M; Valente M; Rea F; Perissinotto E; Agostini C
Thorax; 2008 Sep; 63(9):795-802. PubMed ID: 18344408
[TBL] [Abstract][Full Text] [Related]
10. Small cells in hepatoblastoma lack "oval" cell phenotype.
Badve S; Logdberg L; Lal A; de Davila MT; Greco MA; Mitsudo S; Saxena R
Mod Pathol; 2003 Sep; 16(9):930-6. PubMed ID: 13679457
[TBL] [Abstract][Full Text] [Related]
11. The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy.
Wu F; Wu L; Zheng S; Ding W; Teng L; Wang Z; Ma Z; Zhao W
Dig Liver Dis; 2006 Jul; 38(7):490-7. PubMed ID: 16627020
[TBL] [Abstract][Full Text] [Related]
12. Opposite roles of human pancreatitis-associated protein and REG1A expression in hepatocellular carcinoma: association of pancreatitis-associated protein expression with low-stage hepatocellular carcinoma, beta-catenin mutation, and favorable prognosis.
Yuan RH; Jeng YM; Chen HL; Hsieh FJ; Yang CY; Lee PH; Hsu HC
Clin Cancer Res; 2005 Apr; 11(7):2568-75. PubMed ID: 15814635
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study.
Aronson DC; Schnater JM; Staalman CR; Weverling GJ; Plaschkes J; Perilongo G; Brown J; Phillips A; Otte JB; Czauderna P; MacKinlay G; Vos A
J Clin Oncol; 2005 Feb; 23(6):1245-52. PubMed ID: 15718322
[TBL] [Abstract][Full Text] [Related]
14. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
Fuchs J; Rydzynski J; Von Schweinitz D; Bode U; Hecker H; Weinel P; Bürger D; Harms D; Erttmann R; Oldhafer K; Mildenberger H;
Cancer; 2002 Jul; 95(1):172-82. PubMed ID: 12115331
[TBL] [Abstract][Full Text] [Related]
15. Amplification and overexpression of the IGF2 regulator PLAG1 in hepatoblastoma.
Zatkova A; Rouillard JM; Hartmann W; Lamb BJ; Kuick R; Eckart M; von Schweinitz D; Koch A; Fonatsch C; Pietsch T; Hanash SM; Wimmer K
Genes Chromosomes Cancer; 2004 Feb; 39(2):126-37. PubMed ID: 14695992
[TBL] [Abstract][Full Text] [Related]
16. SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis.
Turato C; Vitale A; Fasolato S; Ruvoletto M; Terrin L; Quarta S; Ramirez Morales R; Biasiolo A; Zanus G; Zali N; Tan PS; Hoshida Y; Gatta A; Cillo U; Pontisso P
Br J Cancer; 2014 May; 110(11):2708-15. PubMed ID: 24809782
[TBL] [Abstract][Full Text] [Related]
17. [Results of the HB-89 Study in treatment of malignant epithelial liver tumors in childhood and concept of a new HB-94 protocol].
von Schweinitz D; Bürger D; Bode U; Weinel P; Erttmann R; Hecker H; Mildenberger H
Klin Padiatr; 1994; 206(4):282-8. PubMed ID: 7526028
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of glutamine synthetase and cytochrome P450 isoforms in human hepatoblastoma.
Schmidt A; Braeuning A; Ruck P; Seitz G; Armeanu-Ebinger S; Fuchs J; Warmann SW; Schwarz M
Toxicology; 2011 Mar; 281(1-3):7-14. PubMed ID: 21237236
[TBL] [Abstract][Full Text] [Related]
19. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
Yuan RH; Jeng YM; Chen HL; Lai PL; Pan HW; Hsieh FJ; Lin CY; Lee PH; Hsu HC
J Pathol; 2006 Aug; 209(4):549-58. PubMed ID: 16739096
[TBL] [Abstract][Full Text] [Related]
20. Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma.
Iolascon A; Giordani L; Moretti A; Basso G; Borriello A; Della Ragione F
Hepatology; 1998 Apr; 27(4):989-95. PubMed ID: 9537438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
